In 2009, I had a remarkable encounter at the Institute for Advanced Studies — I met Freeman Dyson. Known for his groundbreaking work in physics and mathematics, I was struck by his intellect, his way of thinking, and most of all, his rigorous scientific approach to...
Healthcare is a sector that employs many people—some argue too many in wealthier countries, while others believe there are too few in poorer regions. Yet, in more affluent nations, healthcare provides a stable income for a significant number of individuals. What...
Last week, I attended a conference hosted by EFPIA in Brussels. The presentations were well delivered, the panels insightful, and the conversations meaningful. And yet I left with a sense of restlessness. The congress focused on the latest developments in research and...
When are we truly doing good? This is a question that continually drives our organisation. As a patient advocacy group, our mission is to support cancer patients and work towards their well-being. In my view, we are doing good when we help others to flourish and...
Are clinical trials designed to benefit patients, or are they primarily intended to facilitate the registration of new medicines? Why are trials initiated by the pharmaceutical industry, physicians, and researchers—but not with patients? Patients and patient advocates...
